Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Berkeley Premium bankrupt

This article was originally published in The Tan Sheet

Executive Summary

The much-maligned marketer of Enzyte "natural male enhancement" supplement files for Chapter 11 bankruptcy protection Sept. 16. Cincinnati-based Berkeley Premium Nutraceuticals submits its petition to the U.S. Bankruptcy Court for the Southern District of Ohio declaring about $500 million in unsecured claims owed to its 20 largest creditors, including a $459.5 million forfeiture to the federal government ordered Aug. 27. The bankruptcy petition notes that "the debtor's problems began in approximately 2004" with a Federal Trade Commission investigation into "alleged improper marketing activities," and culminated in August with the criminal sentencing of the firm's founder after convictions of money laundering, conspiracy and fraud (1"The Tan Sheet" Sept. 1, 2008, p. 3)

You may also be interested in...

Berkeley Premium sold

Pristine Bay LLC, an Ohio real estate development entity, purchases Cincinnati-based Berkeley Premium Nutraceuticals in a bankruptcy auction for $2.75 million, says attorney Kim Martin Lewis. A judge in the U.S. Bankruptcy Court for the Southern District of Ohio, Western Division, approved the sale Dec. 11, but it likely will not close for a few weeks, according to Lewis, a partner in the Cincinnati office of Dinsmore & Shohl. Berkeley Premium filed for Chapter 11 protection in September (1"The Tan Sheet" Sept. 22, 2008, In Brief)

Enzyte Marketers’ Prison Time Could Scare Firms Off Fraudulent Claims

In a decision that will make executives think twice before taking part in making false claims and other deceptive behavior, an Ohio court sentenced 11 former employees of Berkeley Premium Nutraceuticals to prison for conspiracy, fraud and money laundering convictions related to marketing its Enzyte "natural male enhancement" product

Roche Bulks Up In NLRP3 With €380m Inflazome Buy

Having acquired Jecure Therapeutics and its preclinical portfolio of NLRP3 inhibitors just under two years ago, the Swiss giant has swooped in to buy Dublin-based Inflazome and expand its presence in a hot field of inflammatory research.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts